Evidence map›Paper›PMID 35851568›Full record

Observational studyAnnals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia2022

Prognosis for Mitral Valve Repair Surgery in Functional Mitral Regurgitation.

Rafael Campos-Arjona, Jorge Rodríguez-Capitán, José D Martínez-Carmona, Alexey Lavreshin, Loudes Fernández-Romero, José M Melero-Tejedor, Manuel Jiménez-Navarro

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Rafael Campos-ArjonaDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
Jorge Rodríguez-CapitánDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
José D Martínez-CarmonaDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
Alexey LavreshinDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
Loudes Fernández-RomeroDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
José M Melero-TejedorDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
Manuel Jiménez-NavarroDepartment of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain.
Centro de Investigación en Red en Enfermedades Cardiovasculares · ESInstituto de Investigación Biomédica de Málaga · ESInstituto de Salud Carlos III · ESHospital Clínico Universitario Virgen de la Victoria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOur aim was to evaluate the development of new significant mitral regurgitation and long-term survival after mitral repair surgery in functional mitral regurgitation.

methodsA retrospective observational analysis of the recurrence of functional mitral regurgitation (ischemic and nonischemic) and global mortality during follow-up of 176 patients who underwent mitral repair surgery between 1999 and 2018 in our center was conducted.

resultsThe etiology of functional mitral regurgitation was ischemic in 55.7% of cases. After surgery, mitral regurgitation was 0-I in 92.3% of cases. We conducted a long-term clinical follow-up of a mean 42.2 months and an echocardiographic follow-up of a mean 41.8 months. We observed mitral regurgitation of at least grade II in 52 patients (36.9%). Survival at 1, 3, and 5 years was 78.8%, 66.7%, and 52.3%, respectively. Predictive factors for global mortality were age (hazard ratio = 1.038, p = 0.01) and a depressed preoperative ejection fraction. After a competing risk analysis, we found the only predictive factor for the recurrence of mitral regurgitation in our series to be age (sub-hazard ratio = 1.03, 95% confidence interval = 1.01-1.06, p = 0.016).

conclusionRepair surgery for functional mitral regurgitation shows age as the only independent predictor of recurrence. Age and depressed ejection fraction were predictors of mortality.

Indexed as

Mitral Valve InsufficiencyHumansMitral ValvePrognosisRetrospective StudiesTreatment Outcomefunctional mitral regurgitationmitral regurgitationmitral valve repairmitral valve surgeryrecurrent mitral regurgitation

Identifiers

PMID35851568
PMCPMC9585337
OpenAlexW4285507144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.